Abstract:International Journal of Biomathematics, Ahead of Print. Drug–target interaction (DTI) is a widely explored topic in the field of bioinformatics and plays a pivotal role in drug discovery. However, the traditional bio-experimental process of drug–target interaction identification requires a large investment of time and labor. To address this challenge, graph neural network (GNN) approaches in deep learning are becoming a prominent trend in the field of DTI research, which is characterized by multimodal processing of data, feature learning and interpretability in DTI. Nevertheless, some methods are still limited by homogeneous graphs and single features. To address the problems, we mechanistically analyze graph convolutional neural networks (GCNs) and graph attentional neural networks (GATs) to propose a new model for the prediction of drug–target interactions using graph neural networks named BiTGNN [Bidirectional Transformer (Bi-Transformer)–graph neural network]. The method first establishes drug–target pairs through the pseudo-position specificity scoring matrix (PsePSSM) and drug fingerprint data, and constructs a heterogeneous network by utilizing the relationship between the drug and the target. Then, the computational extraction of drug and target attributes is performed using GCNs and GATs for the purpose of model information flow extension and graph information enhancement. We collect interaction data using the proposed Bi-Transformer architecture, in which we design a bidirectional cross-attention mechanism for calculating the effects of drug–target interactions for realistic biological interaction simulations. Finally, a feed-forward neural network is used to obtain the feature matrices of the drug and the target, and DTI prediction is performed by fusing the two feature matrices. The Enzyme, Ion Channel (IC), G Protein-coupled Receptor (GPCR) and Nuclear Receptor (NR) datasets are used in the experiments, and compared with several existing mainstream models, our model outperforms in Area Under the ROC Curve (AUC), Specificity, Accuracy and the metric Area Under the Precision–Recall Curve (AUPR).

Drug-Target Interaction Prediction Based on Knowledge Graph Embedding and BiLSTM Networks.

Drug-Drug Interaction Prediction Based on Knowledge Graph Embeddings and Convolutional-LSTM Network

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM

Predicting Drug-Target Interactions Using Restricted Boltzmann Machines

A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug–Target Interaction Prediction

Prediction of Drug-target Interactions from Heterogeneous Information Network Based on LINE Embedding Model

Prediction of Drug–Target Interaction Using Dual-Network Integrated Logistic Matrix Factorization and Knowledge Graph Embedding

BiTGNN: Prediction of drug–target interactions based on bidirectional transformer and graph neural network on heterogeneous graph

Predicting Drug-Target Interactions with Deep-Embedding Learning of Graphs and Sequences.

Prediction of Drug-Target Interactions from Multi-Molecular Network Based on LINE Network Representation Method

Advancing drug–target interaction prediction: a comprehensive graph-based approach integrating knowledge graph embedding and ProtBert pretraining

Drug-Drug Interaction Prediction on a Biomedical Literature Knowledge Graph

Drug-target interaction prediction using semi-bipartite graph model and deep learning

EmbedDTI: Enhancing the Molecular Representations via Sequence Embedding and Graph Convolutional Network for the Prediction of Drug-Target Interaction

Prediction of Drug-Target Interactions Based on Multi-Layer Network Representation Learning

Predicting Rich Drug-Drug Interactions via Biomedical Knowledge Graphs and Text Jointly Embedding

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

Prediction of adverse drug reactions based on knowledge graph embedding

Drug-target interaction prediction by integrating heterogeneous information with mutual attention network

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.

KGNN: Knowledge Graph Neural Network for Drug-Drug Interaction Prediction